成大生物
(688739)
| 流通市值：54.39亿 | | | 总市值：119.98亿 |
| 流通股本：1.89亿 | | | 总股本：4.16亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,590,885,490.11 | 4,547,961,783.28 | 4,002,196,670.58 | 4,005,297,932.59 |
| 应收票据及应收账款 | 1,101,472,743.09 | 1,082,158,497.94 | 1,215,827,000.91 | 1,179,465,150.66 |
| 应收账款 | 1,101,472,743.09 | 1,082,158,497.94 | 1,215,827,000.91 | 1,179,465,150.66 |
| 预付款项 | 34,402,383.56 | 29,784,661.05 | 38,899,313.57 | 35,637,780.02 |
| 其他应收款合计 | 6,169,548.85 | 11,905,992.85 | 2,746,529.25 | 1,711,979.25 |
| 存货 | 455,193,773.93 | 422,423,625.55 | 428,993,483.68 | 458,286,571.82 |
| 其他流动资产 | 60,505,170.25 | 60,504,640.36 | 30,322,435.88 | 303,680,869.95 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 7,237,358,260.25 | 7,248,921,187.32 | 7,303,760,940.34 | 7,318,713,498.14 |
| 非流动资产: | | | | |
| 长期股权投资 | 109,242,395.22 | 110,521,418.31 | 171,745,433.2 | 171,271,024.7 |
| 其他非流动金融资产 | 112,474,551.79 | 114,548,298.88 | 114,253,928.15 | 118,565,850.01 |
| 固定资产 | 1,434,794,015.48 | 1,425,521,586.35 | 1,202,696,616.45 | 1,200,499,797.13 |
| 在建工程 | 437,804,194.99 | 438,823,221.28 | 558,537,625.98 | 377,361,687.5 |
| 使用权资产 | 18,955,515.84 | 20,181,347.25 | 21,835,118.09 | 20,542,915.64 |
| 无形资产 | 177,338,557.25 | 178,872,744.62 | 186,471,253.38 | 186,328,349.17 |
| 开发支出 | 399,743,729.99 | 363,385,650.03 | 329,232,481.48 | 280,501,759.49 |
| 长期待摊费用 | 16,945,771.13 | 17,980,335.26 | 19,014,899.39 | 20,049,463.52 |
| 递延所得税资产 | 32,696,111.43 | 42,392,273.63 | 48,135,004.61 | 40,598,506.45 |
| 其他非流动资产 | 125,208,579.4 | 120,211,022.26 | 200,993,871.52 | 260,424,313.76 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,865,203,422.52 | 2,832,437,897.87 | 2,852,916,232.25 | 2,676,143,667.37 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,102,561,682.77 | 10,081,359,085.19 | 10,156,677,172.59 | 9,994,857,165.51 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 221,871,119.78 | 215,079,932.78 | 220,596,435.02 | 177,675,523.33 |
| 应付账款 | 221,871,119.78 | 215,079,932.78 | 220,596,435.02 | 177,675,523.33 |
| 合同负债 | 2,998,987.91 | 1,969,380.18 | 710,632.1 | 434,280.88 |
| 应付职工薪酬 | 52,596,439.19 | 100,676,182.07 | 77,579,448.65 | 65,316,278.7 |
| 应交税费 | 42,763,808.74 | 33,431,560.62 | 52,422,348.51 | 50,744,997.05 |
| 其他应付款合计 | 879,906.52 | 763,913.99 | 1,023,747.79 | 854,439.8 |
| 应付股利 | 283,200 | 283,200 | 306,000 | 306,000 |
| 一年内到期的非流动负债 | 4,966,870.27 | 4,864,198.91 | 4,775,135.35 | 4,234,454.56 |
| 其他流动负债 | 27,360.1 | 660.58 | 17,614.83 | - |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 326,104,492.51 | 356,785,829.13 | 357,125,362.25 | 299,259,974.32 |
| 非流动负债: | | | | |
| 租赁负债 | 14,699,325.72 | 15,141,489.49 | 17,902,966.39 | 15,770,766.4 |
| 递延收益 | 97,718,408.94 | 100,793,903.43 | 103,467,163.92 | 106,004,076.08 |
| 递延所得税负债 | 458,283.26 | 9,496,223.38 | 6,658,660.44 | 7,008,605.97 |
| 其他非流动负债 | 3,100 | 12,400 | 9,300 | 6,254 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 112,879,117.92 | 125,444,016.3 | 128,038,090.75 | 128,789,702.45 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 438,983,610.43 | 482,229,845.43 | 485,163,453 | 428,049,676.77 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 416,450,000 | 416,450,000 | 416,450,000 | 416,450,000 |
| 资本公积 | 5,034,174,119.54 | 5,034,174,119.54 | 5,034,174,119.54 | 5,034,174,119.54 |
| 减:库存股 | 117,005,156.39 | 99,990,287.88 | 25,199,802.25 | - |
| 盈余公积 | 208,225,000 | 208,225,000 | 208,225,000 | 208,225,000 |
| 未分配利润 | 4,121,734,109.19 | 4,040,270,408.1 | 4,037,864,402.3 | 3,907,958,369.2 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 9,663,578,072.34 | 9,599,129,239.76 | 9,671,513,719.59 | 9,566,807,488.74 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 9,663,578,072.34 | 9,599,129,239.76 | 9,671,513,719.59 | 9,566,807,488.74 |
| 负债和股东权益合计 | 10,102,561,682.77 | 10,081,359,085.19 | 10,156,677,172.59 | 9,994,857,165.51 |
| 公告日期 | 2024-04-30 | 2024-04-23 | 2023-10-27 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |